The 19 restricted peptides spanned nearly every major clinical category in peptide therapy: tissue repair (BPC-157, Thymosin Beta-4), immune modulation (Thymosin Alpha-1, Selank), growth hormone signaling (CJC-1295, Ipamorelin, GHRP-2, GHRP-6), metabolic support (AOD-9604, MOTS-C), cognitive health (Semax, Selank), wound healing (GHK-Cu), and others including KPV, Kisspeptin-10, Melanotan II, PEG-MGF, Epitalon, Cathelicidin LL-37, and Emideltide (DSIP)
Ipamorelin's durable contribution, as recognized in the primary literature, is its demonstration that GHS-R1a agonism could be pharmacologically dissociated from co-stimulation of the hypothalamic-pituitary-adrenal axis, evidence of signal diversity at the receptor that informed subsequent compound design
Mycotoxin and gut microbiota interactions
doi:10.1093/cid/ciaa1443 126 Yoon, H